The solution has still only been approved in the United States for investigational use.
This secondary analysis of data from the FIDELIO-DKD trial was presented May 17 at ACC.21 and published in the Journal of the American College of Cardiology.
The study's authors believe they are the first group to investigate the real-time relationship between alcohol consumption and AFib events.
Researchers explored data from the GALACTIC-HF trial to evaluate how the severity of a patient's reduced ejection fraction impacts the benefits of omecamtiv mecarbil.
“This is a procedure that’s done once, and it keeps giving a benefit over time,” one researcher said. “This is going to prevent thousands of strokes.”
Cardiologists are confident COVID-related shortfalls will soon be behind them, according to the report.
The FDA has received complaints about 135 injuries so far.
The ACC is enthusiastically backing the bipartisan legislation, saying it would improve care for the country's cardiovascular patients.
Percutaneous edge-to-edge mitral valve repair was associated with improved outcomes among TAVR patients with persistent mitral regurgitation.
Though this does not seem to be a significant issue, the agency still recommends keeping consumer electronics at least six inches away from implanted medical devices.
“Our findings suggest that cardiologists should consider the value of regular psychological assessments, especially among younger patients,” one researcher said. The team's full findings will be presented at ACC.21.
The authors evaluated data from more than 2.1 million patients, sharing their findings in Circulation.